Consolidated Portfolio Review Corp’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,520	Closed	-$1.23M	–	198
2025 Q3	$1.23M	Buy	50,520 +3,003	+6%	+$72.8K	0.15%	148
2025 Q2	$1.15M	Buy	47,517 +3,687	+8%	+$89K	0.16%	145
2025 Q1	$1.06M	Buy	43,830 +5,263	+14%	+$127K	0.17%	137
2024 Q4	$924K	Buy	38,567 +5,714	+17%	+$138K	0.15%	164
2024 Q3	$801K	Buy	32,853 +1,922	+6%	+$46.3K	0.18%	145
2024 Q2	$734K	Buy	30,931 +4,487	+17%	+$106K	0.17%	148
2024 Q1	$629K	Buy	+26,444	New	+$630K	0.17%	143

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Consolidated Portfolio Review Corp's IBDS Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q4 2025, closing a stake of 50,520 shares — an estimated $1.23M sold.

Consolidated Portfolio Review Corp first reported a position in IBDS in Q1 2024 and held it in 7 quarters. The position peaked at $1.23M in Q3 2025. 415 funds tracked by Wall St. Rank hold IBDS as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 50,520 iShares iBonds Dec 2027 Term Corporate ETF shares in Q4 2025, an estimated $1.23M.
Consolidated Portfolio Review Corp first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and held it in 7 quarters.
Consolidated Portfolio Review Corp's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $1.23M in Q3 2025.
415 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.